Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 30 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Carcinoma, Non-Small-Cell Lung  [Clear All Filters]
2019
Zarogoulidis, P., Kosmidis C., Fyntanidou V., Barmpas A., Koulouris C., Aidoni Z., et al. (2019).  Elastography during convex-probe (endobronchial ultrasound) for optimal biopsy sample and gene identification in non-small-cell lung cancer.. Biomark Med. 13(14), 1153-1156.
Zarogoulidis, P., Sapalidis K., Fyntanidou V., Kosmidis C., Amaniti A., Koulouris C., et al. (2019).  Evaluating the use of elastography in endobronchial ultrasound technique as a diagnostic approach for mesothorax lymphadenopathy.. Expert Rev Respir Med. 13(12), 1153-1159.
Linardou, H., Kotoula V., Kouvatseas G., Mountzios G., Karavasilis V., Samantas E., et al. (2019).  Genotyping and Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.. Cancer Genomics Proteomics. 16(6), 531-541.
Kosmidis, C., Sapalidis K., Zarogoulidis P., Sardeli C., Koulouris C., Giannakidis D., et al. (2019).  Inhaled Cisplatin for NSCLC: Facts and Results.. Int J Mol Sci. 20(8), 
2018
Fountzilas, E., Levva S., Mountzios G., Polychronidou G., Maniadakis N., Kotoula V., et al. (2018).  Treating EGFR-Mutated Oncogene-Addicted Advanced Non-Small-Cell Lung Cancer in the Era of Economic Crisis in Greece: Challenges and Opportunities.. J Glob Oncol. 4, 1-12.
2016
Matikas, A., Kentepozidis Ν., Ardavanis A., Vaslamatzis M., Polyzos A., Emmanouilides C., et al. (2016).  Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).. Cancer Chemother Pharmacol. 78(2), 369-76.
Mantsou, A., Koutsogiannouli E., Haitoglou C., Papavassiliou A. G., & Papanikolaou N. A. (2016).  Regulation of expression of the p21 gene by the transcription factor ZNF217 and MDM2.. Biochem Cell Biol. 94(6), 560-568.
2015
Kotoula, V., Bobos M., Vassilakopoulou M., Tsolaki E., Chrisafi S., Psyrri A., et al. (2015).  Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).. Appl Immunohistochem Mol Morphol. 23(1), 60-70.
Zarogoulidis, P., Petanidis S., Kioseoglou E., Domvri K., Anestakis D., & Zarogoulidis K. (2015).  MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.. Cell Signal. 27(8), 1576-88.
2014
Karavasilis, V., Kosmidis P., Syrigos K. N., Mavropoulou P., Dimopoulos M. A., Kotoula V., et al. (2014).  Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.. Anticancer Res. 34(10), 5649-55.
Ntikoudi, E., Kiagia M., Boura P., & Syrigos K. N. (2014).  Hormones of adipose tissue and their biologic role in lung cancer.. Cancer Treat Rev. 40(1), 22-30.
2013
Briasoulis, E., Aravantinos G., Kouvatseas G., Pappas P., Biziota E., Sainis I., et al. (2013).  Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.. BMC Cancer. 13, 263.
Darwiche, K., Zarogoulidis P., Karamanos N. K., Domvri K., Chatzaki E., Constantinidis T. C., et al. (2013).  Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology.. Future Oncol. 9(4), 505-25.
Raptakis, T., Boura P., Tsimpoukis S., Gkiozos I., & Syrigos K. N. (2013).  Endoscopic and endobronchial ultrasound-guided needle aspiration in the mediastinal staging of non-small cell lung cancer.. Anticancer Res. 33(6), 2369-76.
Hohenforst-Schmidt, W., Zarogoulidis P., Darwiche K., Vogl T., Goldberg E. P., Huang H., et al. (2013).  Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.. Drug Des Devel Ther. 7, 571-83.
Zarogoulidis, P., Yarmus L., & Zarogoulidis K. (2013).  New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.. Ther Deliv. 4(10), 1221-3.
2012
Kotoula, V., Krikelis D., Karavasilis V., Koletsa T., Eleftheraki A. G., Televantou D., et al. (2012).  Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS).. BMC Cancer. 12, 342.
Zarogoulidis, P., Eleftheriadou E., Sapardanis I., Zarogoulidou V., Lithoxopoulou H., Kontakiotis T., et al. (2012).  Feasibility and effectiveness of inhaled carboplatin in NSCLC patients.. Invest New Drugs. 30(4), 1628-40.
Mylonaki, E., Manika K., Zarogoulidis P., Domvri K., Voutsas V., Zarogoulidis K., et al. (2012).  In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy.. Mutat Res. 740(1-2), 1-5.
Zarogoulidis, P., Chatzaki E., Hohenforst-Schmidt W., Goldberg E. P., Galaktidou G., Kontakiotis T., et al. (2012).  Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.. Cancer Gene Ther. 19(9), 593-600.
Murray, S., Karavasilis V., Bobos M., Razis E., Papadopoulos S., Christodoulou C., et al. (2012).  Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer.. J Exp Clin Cancer Res. 31, 77.
Glattki, G. P., Manika K., Sichletidis L., Alexe G., Brenke R., & Spyratos D. (2012).  Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.. Am J Clin Oncol. 35(2), 120-5.
Kosmidis, P. A., Syrigos K., Kalofonos H. P., Dimopoulos M-A., Skarlos D., Pavlidis N., et al. (2012).  Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.. Anticancer Res. 32(1), 175-81.
2011
Kosmidis, P. A., Fountzilas G., Eleftheraki A. G., Kalofonos H. P., Pentheroudakis G., Skarlos D., et al. (2011).  Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).. Ann Oncol. 22(4), 827-34.
2010
Chelis, L., Xenidis N., Amarantidis K., Prassopoulos P., Chamalidou E., Neanidis K., et al. (2010).  Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer.. Chemotherapy. 56(5), 353-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές